• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于可靠且灵敏地测量强直性肌营养不良症握力性肌强直的简单经济的手部紧握放松计装置。

Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophy.

作者信息

Bulea Thomas C, Guth Amanda, Sarkar Nathan, Gravunder Andrew, Hodsdon Bonnie, Farrell Kathleen, Comis Leora E, Parks Rebecca, Shimellis Hirity, Ndege Vanessa, Ho Pei-Shu, Mankodi Ami

机构信息

Functional and Applied Biomechanics Section, Rehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, United States of America.

Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, United States of America.

出版信息

Neuromuscul Disord. 2022 Apr;32(4):321-331. doi: 10.1016/j.nmd.2022.02.005. Epub 2022 Feb 14.

DOI:10.1016/j.nmd.2022.02.005
PMID:35305880
Abstract

Grip myotonia and weakness are attractive treatment response biomarkers in clinical trials of myotonic dystrophy type 1 (DM1). There is a need to develop simple, patient-friendly and reproducible methods of quantifying grip myotonia in multisite trial settings. We designed a HandClench Relaxometer (HCR) that measures grip myotonia and strength. In contrast with the existing quantitative myometry (QMA) setup, the HCR is portable, economical, can be used with any laptop and generates automated command prompts. We demonstrate the feasibility and reliability of HCR device in twenty DM1 individuals and ten age-matched controls; patients returned for follow up within two months. The device showed excellent day to day reproducibility (ICC >0.80) in patients. The HCR device detected myotonia in milder muscle disease and measured longer myotonia duration than QMA indicating enhanced sensitivity for quantifying myotonia in DM1. The reaction time to the relax but not squeeze command was delayed and showed warm up similar to myotonia in DM1. HCR outcomes were correlated with key pinch strength, hand dexterity test, and fat replacement in the MRI of the long finger flexor muscles. Use of the HCR is warranted for grip myotonia and strength measurements in longitudinal observational and interventional studies of DM1.

摘要

在1型强直性肌营养不良(DM1)的临床试验中,握力性肌强直和肌无力是颇具吸引力的治疗反应生物标志物。在多中心试验环境中,需要开发简单、对患者友好且可重复的方法来量化握力性肌强直。我们设计了一种手部紧握松弛计(HCR),用于测量握力性肌强直和力量。与现有的定量肌动测量法(QMA)设置不同,HCR便于携带、经济实惠,可以与任何笔记本电脑配合使用,并能生成自动命令提示符。我们在20名DM1患者和10名年龄匹配的对照者中证明了HCR设备的可行性和可靠性;患者在两个月内返回进行随访。该设备在患者中显示出出色的每日可重复性(组内相关系数>0.80)。HCR设备在较轻的肌肉疾病中检测到了肌强直,并且测量到的肌强直持续时间比QMA更长,这表明其在量化DM1中的肌强直方面具有更高的灵敏度。对放松命令而非挤压命令的反应时间延迟,并且显示出与DM1中的肌强直类似的热身现象。HCR的结果与关键捏力、手部灵活性测试以及长指屈肌MRI中的脂肪替代相关。在DM1的纵向观察性研究和干预性研究中,有必要使用HCR来测量握力性肌强直和力量。

相似文献

1
Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophy.用于可靠且灵敏地测量强直性肌营养不良症握力性肌强直的简单经济的手部紧握放松计装置。
Neuromuscul Disord. 2022 Apr;32(4):321-331. doi: 10.1016/j.nmd.2022.02.005. Epub 2022 Feb 14.
2
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2025 Apr 8;4(4):CD004762. doi: 10.1002/14651858.CD004762.pub3.
3
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004762. doi: 10.1002/14651858.CD004762.pub2.
4
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.评估拉莫三嗪作为1型强直性肌营养不良症(DM1)抗肌强直药物的安全性和有效性:一项纵向、开放标签的试点研究。
Neurol Ther. 2025 Oct;14(5):2249-2260. doi: 10.1007/s40120-025-00804-z. Epub 2025 Aug 2.
5
Corticosteroids for the treatment of Duchenne muscular dystrophy.用于治疗杜氏肌营养不良症的皮质类固醇
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4.
6
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).计算机化握力肌测量法能够可靠地测量强直性肌营养不良症(DM1)中的肌强直和肌肉力量。
Muscle Nerve. 2007 Sep;36(3):320-8. doi: 10.1002/mus.20822.
9
Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb.生物工程神经导管和套用于上肢周围神经修复。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD012574. doi: 10.1002/14651858.CD012574.pub2.
10
Strength training and aerobic exercise training for muscle disease.针对肌肉疾病的力量训练和有氧运动训练。
Cochrane Database Syst Rev. 2013 Jul 9(7):CD003907. doi: 10.1002/14651858.CD003907.pub4.

引用本文的文献

1
Measuring Myotonia: Normative Values and Comparison with Myotonic Dystrophy Type 1.测量肌强直:正常参考值及与1型强直性肌营养不良的比较
Neurol Int. 2025 Jul 31;17(8):118. doi: 10.3390/neurolint17080118.
2
All hands on deck: The multidisciplinary rehabilitation assessment and management of hand function in persons with neuromuscular disorders.全员出动:神经肌肉疾病患者手部功能的多学科康复评估与管理
Muscle Nerve. 2025 May;71(5):869-888. doi: 10.1002/mus.28167. Epub 2024 Jun 6.

本文引用的文献

1
The neural mechanisms of manual dexterity.手工灵巧的神经机制。
Nat Rev Neurosci. 2021 Dec;22(12):741-757. doi: 10.1038/s41583-021-00528-7. Epub 2021 Oct 28.
2
White matter microstructure relates to motor outcomes in myotonic dystrophy type 1 independently of disease duration and genetic burden.脑白质微观结构与肌强直性营养不良 1 型的运动结果有关,与疾病持续时间和遗传负担无关。
Sci Rep. 2021 Mar 1;11(1):4886. doi: 10.1038/s41598-021-84520-2.
3
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
基于全州血液筛查计划的遗传分析的 1 型肌强直性营养不良的人群患病率。
Neurology. 2021 Feb 16;96(7):e1045-e1053. doi: 10.1212/WNL.0000000000011425. Epub 2021 Jan 20.
4
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.美西律治疗 1 型肌强直性营养不良症:一项随机、双盲、安慰剂对照试验。
Neurology. 2021 Jan 12;96(2):e228-e240. doi: 10.1212/WNL.0000000000011002. Epub 2020 Oct 12.
5
Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.使用市售测力计对 1 型和 2 型肌强直性营养不良进行定量肌强直评估。
Muscle Nerve. 2019 Apr;59(4):431-435. doi: 10.1002/mus.26401. Epub 2019 Jan 9.
6
Diffusion tensor imaging and voxel-based morphometry reveal corticospinal tract involvement in the motor dysfunction of adult-onset myotonic dystrophy type 1.弥散张量成像和基于体素的形态测量学显示皮质脊髓束参与成年型肌强直性营养不良 1 型的运动功能障碍。
Sci Rep. 2018 Oct 22;8(1):15592. doi: 10.1038/s41598-018-34048-9.
7
Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.验证九孔钉测试作为肌强直性营养不良症 1 型灵巧度的测量方法。
Neuromuscul Disord. 2018 Nov;28(11):947-951. doi: 10.1016/j.nmd.2018.08.011. Epub 2018 Aug 31.
8
Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015.1型强直性肌营养不良症第三次结局测量(OMMYD - 3)国际研讨会报告,法国巴黎,2015年6月8日
J Neuromuscul Dis. 2018;5(4):523-537. doi: 10.3233/JND-180329.
9
Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity.迈向1型强直性肌营养不良更个性化的运动功能康复:神经可塑性的作用。
PLoS One. 2017 May 25;12(5):e0178470. doi: 10.1371/journal.pone.0178470. eCollection 2017.
10
Advances in assessing myotonia: Can sensor-engineered glove have a role?评估肌强直的进展:传感器设计的手套能发挥作用吗?
J Neurol Sci. 2017 Apr 15;375:3-7. doi: 10.1016/j.jns.2017.01.038. Epub 2017 Jan 12.